Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
  • United Kingdom
  • France
  • Sweden
Investment stages
  • Seed
Industries
  • Pharma
  • Diagnostics
  • Biotechnology
  • Health Tech
About
Genoa Ventures focuses on investing in early-stage companies that are pioneering innovations at the convergence of biology and technology.
Min check size
$1M
Max check size
$5M
Fund size
NPS

Investment Thesis

They invest in life sciences research tools, diagnostics, synthetic biology, industrial biotech, consumer bio and noninvasive medical devices
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Bringing a wealth of expertise, the fund manager has successfully executed over 30 investments across technology and healthcare sectors, primarily in North America and Europe. With a strategic focus on early-stage ventures, their operator-first approach has facilitated several notable exits, demonstrating an ability to identify high-potential opportunities. The manager emphasizes a data-driven decision-making process, ensuring comprehensive analysis during each investment cycle. This unique blend of experience and strategic insight positions them as a formidable player in the investment landscape.

Genoa Ventures Contacts Information

Primary contact

Team

Jenny Rooke

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp